RQx lands funding through hard work and luck

11/29/2012 | Xconomy

RQx Pharmaceuticals was born after researcher Floyd Romesberg and investor Court Turner happened to strike up a conversation in a local coffee shop. Romesberg is developing arylomycin to work against gram-negative and -positive bacteria, potentially leading to a new broad-spectrum antibiotic. Turner's company, Avalon Ventures, provided the first $1 million for Romesberg to start a new company, and Correlation Ventures has since joined as a venture investor.

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC